A national cross-sectional analysis of surveillance drug resistance mutations among recently diagnosed antiretroviral naïve Brazilian people with HIV
{{output}}
Background: Brazil pioneered free and universal HIV antiretroviral therapy (ART) access in 1996. This study evaluated the prevalence of surveillance drug resistance mutations (SDRM) among individuals newly diagnosed with HIV and ... ...
